Skip to content

Community Cardiovascular Health Awareness Program

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN50550004
Enrollment
Unknown
Registered
2007-05-09
Start date
2006-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease risk factors Circulatory System Cardiovascular disease risk factors

Interventions

The community pharmacy sessions are weekday three-hour morning sessions over a ten-week period, which entail volunteer Peer Health Educators ensuring that accurate BP recordings and risk factor data a

Sponsors

McMaster University (Canada)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The 39 eligible communities vary in population size from 10,000 to 60,000, and were stratified by population aged 65+ and geographic location, and randomly allocated to CHAP or control. The community mobilisation model aims to involve all family physicians, local pharmacies and relevant organisations in the program communities. The program targets all residents 65 years of age or older through community-wide advertising and invitation via family physicians.

Exclusion criteria

Exclusion criteria: 1. Communities of less than 10,000 residents 2. Fewer than five family physicians and two pharmacies in community

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will look at change in the composite outcome for one year prior to the program to one year following the program, in intervention compared to control communities, using administrative data.

Secondary

MeasureTime frame
Process data will inform evaluation of the success of community mobilisation and program delivery in the intervention communities. Process measures in the program communities include: 1. Assessment of the success of community mobilisation 2. Surveys of volunteers, family physicians, and pharmacists 3. Interviews with coordinators 4. Final reports from lead organisations 5. Learning from a debriefing workshop with all program community partners This data is being collected during the six months following the ten-week program.

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026